Live from the NIH registry
Studies recruiting near Galveston right now
Top 25 of 202 recruiting studies, sorted by proximity — each links to its official registry page
Novel Strategies for Reducing Burn Scar Itch
Burn Scar, Itch Scarring
Phase 3
Interventional 44 participants sought
University of Texas Medical Branch, Galveston — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
Herpes Zoster (HZ), Vascular Dementia
N/A
Observational 375 participants sought
Center for Clinical Studies, LTD. LLP — Webster, Texas (24.2 mi)
· Sponsor: Center for Clinical Studies, Texas
Improving Sleep In Midlife Women
Poor Sleep Quality
N/A
Interventional 72 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
University Of Texas Medical Branch At Galveston — Galveston, Texas (6.7 mi)
· Sponsor: Bristol-Myers Squibb
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
MD Anderson League City — League City, Texas (21.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
UT MD Anderson - League City — League City, Texas (21.7 mi)
· Sponsor: NRG Oncology
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Elevate Clinical Research — Seabrook, Texas (23.3 mi)
· Sponsor: Sparrow Pharmaceuticals
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Spinal Cord Injuries, Urinary Incontinence
Phase 2
Interventional 24 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
SLE, SLE (Systemic Lupus)
Phase 1
Interventional 24 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: Cullinan Therapeutics Inc.
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Webster, Texas (24.2 mi)
· Sponsor: GlaxoSmithKline
Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab
Stroke, Robot Assisted Gait Training
N/A
Interventional 30 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Webster, Texas (24.2 mi)
· Sponsor: Akero Therapeutics, Inc
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
MD Anderson Cancer center — League City, Texas (21.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Seabrook, Texas (23.3 mi)
· Sponsor: GlaxoSmithKline
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Phase 4
Interventional 618 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
XTX301 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 358 participants sought
Tranquil Clinical Research — Webster, Texas (24.2 mi)
· Sponsor: Xilio Development, Inc.
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Breast Cancer, Breast-conserving Surgery
N/A
Interventional 10 participants sought
University of Texas Medical Branch at Galveston, TX — Galveston, Texas (6.7 mi)
· Sponsor: Innoblative Designs, Inc.
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Phase 1
Interventional 42 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: Novo Nordisk A/S
A Study of V132 in Healthy Older Participants (V132-001)
Healthy
Phase 1
Interventional 280 participants sought
University of Texas Medical Branch ( Site 0004) — League City, Texas (21.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Galveston — Galveston, Texas (6.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
Burns
N/A
Interventional 30 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: The University of Texas Medical Branch, Galveston
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Peripheral Neuropathies, Peripheral Neuropathy Due to Chemotherapy
N/A
Interventional 200 participants sought
University of Texas Medical Branch — Galveston, Texas (6.7 mi)
· Sponsor: RxFunction Inc.
Gastroschisis Outcomes of Delivery (GOOD) Study
Gastroschisis
N/A
Interventional 300 participants sought
University of Texas Medical Branch Galveston — Galveston, Texas (6.7 mi)
· Sponsor: Medical College of Wisconsin